This compound is a fluorinated, iodinated pyrimidinedione derivative used as a pharmaceutical intermediate. Its structure features a pyrimidine ring with iodine and methyl substituents, linked to a difluorinated benzyl group bearing a trifluoromethyl moiety.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 1150560-54-5
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
Pharmaceutical intermediate
5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1h,3h)-pyrimidinedione
Pharmaceutical intermediate
2-(2-(((Benzyloxy)carbonyl)amino)thiazol-4-yl)-5-((3-methylbut-2-en-1-yl)oxy)-5-oxopent-2-enoic acid
pharmaceutical intermediate
Ethyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
Pharmaceutical intermediate
5-BROMO-2,3-DIHYDRO-7-AZAINDOLE
pharmaceutical intermediate
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
Pharmaceutical intermediate
Alogliptin impurity
Pharmaceutical impurity reference standard
2-((6-Chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
research compound
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methylpyrimidine-2,4-dione
TZBUKGISILNJCR-UHFFFAOYSA-N
CC1=C(C(=O)NC(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)I
—